|
1
|
Bar-Ad V, Palmer J, Li L, Lai Y, Lu B,
Myers RE, Ye Z, Axelrod R, Johnson JM, Werner-Wasik M, et al:
Neutrophil to lymphocyte ratio associated with prognosis of lung
cancer. Clin Transl Oncol. 19:711–717. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Najmeh S, Cools-Lartigue J, Giannias B,
Spicer J and Ferri LE: Simplified human neutrophil extracellular
traps (NETs) isolation and handling. J Vis Exp. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cools-Lartigue J, Spicer J, McDonald B,
Gowing S, Chow S, Giannias B, Bourdeau F, Kubes P and Ferri L:
Neutrophil extracellular traps sequester circulating tumor cells
and promote metastasis. J Clin Invest. July 1–2013.(Epub ahead of
print). View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oklu R, Sheth RA, Wong KHK, Jahromi AH and
Albadawi H: Neutrophil extracellular traps are increased in cancer
patients but does not associate with venous thrombosis. Cardiovasc
Diagn Ther. 7 (Suppl 3):S140–S149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brinkmann V, Reichard U, Goosmann C,
Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y and Zychlinsky A:
Neutrophil extracellular traps kill bacteria. Science.
303:1532–1535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ben-Smith A, Dove SK, Martin A, Wakelam MJ
and Savage CO: Antineutrophil cytoplasm autoantibodies from
patients with systemic vasculitis activate neutrophils through
distinct signaling cascades: Comparison with conventional Fcgamma
receptor ligation. Blood. 98:1448–1455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clark SR, Ma AC, Tavener SA, McDonald B,
Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair
GD, et al: Platelet TLR4 activates neutrophil extracellular traps
to ensnare bacteria in septic blood. Nat Med. 13:463–469. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitroulis I, Kambas K, Chrysanthopoulou A,
Skendros P, Apostolidou E, Kourtzelis I, Drosos GI, Boumpas DT and
Ritis K: Neutrophil extracellular trap formation is associated with
IL-1beta and autophagy-related signaling in gout. PLoS One.
6:e293182011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta AK, Joshi MB, Philippova M, Erne P,
Hasler P, Hahn S and Resink TJ: Activated endothelial cells induce
neutrophil extracellular traps and are susceptible to
NETosis-mediated cell death. FEBS Lett. 584:3193–3197. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Demers M, Krause DS, Schatzberg D,
Martinod K, Voorhees JR, Fuchs TA, Scadden DT and Wagner DD:
Cancers predispose neutrophils to release extracellular DNA traps
that contribute to cancer-associated thrombosis. Proc Natl Acad Sci
USA. 109:13076–13081. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang R, Zhang Q, Zeh HJ III, Lotze MT and
Tang D: HMGB1 in cancer: Good, bad, or both? Clin Cancer Res.
19:4046–4057. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tadie JM, Bae HB, Jiang S, Park DW, Bell
CP, Yang H, Pittet JF, Tracey K, Thannickal VJ, Abraham E and
Zmijewski JW: HMGB1 promotes neutrophil extracellular trap
formation through interactions with Toll-like receptor 4. Am J
Physiol Lung Cell Mol Physiol. 304:L342–L349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim YH, Okuda C, Sakamori Y, Masago K,
Togashi Y and Mishima M: Continuous morphine infusion for end-stage
lung cancer patients. Oncol Lett. 5:972–974. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zylla D, Kuskowski MA, Gupta K and Gupta
P: Association of opioid requirement and cancer pain with survival
in advanced non-small cell lung cancer. Br J Anaesth. 113 (Suppl
1):i109–i116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nguyen J, Luk K, Vang D, Soto W, Vincent
L, Robiner S, Saavedra R, Li Y, Gupta P and Gupta K: Morphine
stimulates cancer progression and mast cell activation and impairs
survival in transgenic mice with breast cancer. Br J Anaesth. 113
(Suppl 1):i4–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zylla D, Gourley BL, Vang D, Jackson S,
Boatman S, Lindgren B, Kuskowski MA, Le C, Gupta K and Gupta P:
Opioid requirement, opioid receptor expression, and clinical
outcomes in patients with advanced prostate cancer. Cancer.
119:4103–4110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shah M, Anwar MA, Yesudhas D, Krishnan J
and Choi S: A structural insight into the negative effects of
opioids in analgesia by modulating the TLR4 signaling: An in silico
approach. Sci Rep. 6:392712016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shah M and Choi S: Toll-like
Receptor-Dependent Negative Effects of Opioids: A Battle between
Analgesia and Hyperalgesia. Front Immunol. 8:6422017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swamydas M, Luo Y, Dorf ME and Lionakis
MS: Isolation of mouse neutrophils. Curr Protoc Immunol.
110:3.20.1–3.15. 2015. View Article : Google Scholar
|
|
20
|
Behnen M, Leschczyk C, Moller S, Batel T,
Klinger M, Solbach W and Laskay T: Immobilized immune complexes
induce neutrophil extracellular trap release by human neutrophil
granulocytes via Fc gamma RIIIB and Mac-1. J Immunol.
193:1954–1965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brinkmann V and Zychlinsky A: Neutrophil
extracellular traps: Is immunity the second function of chromatin?
J Cell Biol. 198:773–783. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hayashi F, Means TK and Luster AD:
Toll-like receptors stimulate human neutrophil function. Blood.
102:2660–2669. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Neal MD, Jia H, Eyer B, Good M, Guerriero
CJ, Sodhi CP, Afrazi A, Prindle T Jr, Ma C, Branca M, et al:
Discovery and validation of a new class of small molecule Toll-like
receptor 4 (TLR4) inhibitors. PLoS One. 8:e657792013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reino DC, Pisarenko V, Palange D, Doucet
D, Bonitz RP, Lu Q, Colorado I, Sheth SU, Chandler B, Kannan KB, et
al: Trauma hemorrhagic shock-induced lung injury involves a
gut-lymph-induced TLR4 pathway in mice. PLoS One. 6:e148292011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takeda K and Akira S: TLR signaling
pathways. Semin Immunol. 16:3–9. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lapponi MJ, Carestia A, Landoni VI,
Rivadeneyra L, Etulain J, Negrotto S, Pozner RG and Schattner M:
Regulation of neutrophil extracellular trap formation by
anti-inflammatory drugs. J Pharmacol Exp Ther. 345:430–437. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hakkim A, Fuchs TA, Martinez NE, Hess S,
Prinz H, Zychlinsky A and Waldmann H: Activation of the Raf-MEK-ERK
pathway is required for neutrophil extracellular trap formation.
Nat Chem Biol. 7:75–77. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma Y, Kang S, Wu X, Han B, Jin Z and Guo
Z: Up-regulated HMGB1 in the pleural effusion of non-small cell
lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC
cells. Tumori. 104:338–343. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niki M, Yokoi T, Kurata T and Nomura S:
New prognostic biomarkers and therapeutic effect of bevacizumab for
patients with non-small-cell lung cancer. Lung Cancer (Auckl).
8:91–99. 2017.PubMed/NCBI
|
|
30
|
Tamassia N, Le Moigne V, Calzetti F,
Donini M, Gasperini S, Ear T, Cloutier A, Martinez FO, Fabbri M,
Locati M, et al: The MyD88-independent pathway is not mobilized in
human neutrophils stimulated via TLR4. J Immunol. 178:7344–7356.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang QW, Lu FL, Zhou Y, Wang L, Zhong Q,
Lin S, Xiang J, Li JC, Fang CQ and Wang JZ: HMBG1 mediates
ischemia-reperfusion injury by TRIF-adaptor independent Toll-like
receptor 4 signaling. J Cereb Blood Flow Metab. 31:593–605. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carestia A, Kaufman T, Rivadeneyra L,
Landoni VI, Pozner RG, Negrotto S, D'Atri LP, Gómez RM and
Schattner M: Mediators and molecular pathways involved in the
regulation of neutrophil extracellular trap formation mediated by
activated platelets. J Leukoc Biol. 99:153–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Awasthi D, Nagarkoti S, Kumar A, Dubey M,
Singh AK, Pathak P, Chandra T, Barthwal MK and Dikshit M: Oxidized
LDL induced extracellular trap formation in human neutrophils via
TLR-PKC-IRAK-MAPK and NADPH-oxidase activation. Free Radic Biol
Med. 93:190–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu M, Wang H, Ding A, Golenbock DT, Latz
E, Czura CJ, Fenton MJ, Tracey KJ and Yang H: HMGB1 signals through
toll-like receptor (TLR) 4 and TLR2. Shock. 26:174–179. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Plein LM and Rittner HL: Opioids and the
immune system-friend or foe. Br J Pharmacol. 175:2717–2725. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Glattard E, Welters ID, Lavaux T, Muller
AH, Laux A, Zhang D, Schmidt AR, Delalande F, Laventie BJ,
Dirrig-Grosch S, et al: Endogenous morphine levels are increased in
sepsis: A partial implication of neutrophils. PLoS One.
5:e87912010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gregory AD and Houghton AM:
Tumor-associated neutrophils: new targets for cancer therapy.
Cancer Res. 71:2411–2416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Berger-Achituv S, Brinkmann V, Abed UA,
Kuhn LI, Ben-Ezra J, Elhasid R and Zychlinsky A: A proposed role
for neutrophil extracellular traps in cancer immunoediting. Front
Immunol. 4:482013. View Article : Google Scholar : PubMed/NCBI
|
